Semler Scientific Boosts Bitcoin Holdings to 3,192 BTC with $88.5M Investment
Semler Scientific, a leading medical device manufacturer, has expanded its Bitcoin holdings to 3,192 BTC following a strategic investment of $88.5 million. The company acquired an additional 871 BTC between January 11 and February 3, 2025, funding the purchase through proceeds from a senior convertible notes offering and the partial monetization of its stake in Monarch Medical Technologies.
The latest acquisition brings Semler Scientific's average Bitcoin purchase price to $87,854 per BTC, with a total investment of $280.4 million. The company has reported a year-to-date BTC Yield of 21.9% and a 152.2% return since adopting its Bitcoin treasury strategy in July 2024. Chairman Eric Semler expressed enthusiasm about the company's progress in growing its Bitcoin stockpile, stating, "We are thrilled with the progress we are making in growing our bitcoin stockpile."
Semler Scientific's aggressive Bitcoin accumulation strategy contrasts with that of MicroStrategy, which recently paused its 12-week buying spree. MicroStrategy accumulated approximately $20 billion worth of Bitcoin, maintaining total holdings of 471,107 BTC, valued at over $47 billion. The differing approaches between the two companies highlight the evolving landscape of corporate investment in Bitcoin, with Semler Scientific actively expanding its portfolio amidst favorable market conditions while MicroStrategy reassesses its strategy.
The growing interest in Bitcoin among corporations is likely to continue influencing market dynamics as more companies consider diversifying their asset allocations to include digital currencies. Investors are advised to stay informed about the latest developments in corporate cryptocurrency engagements to make well-informed decisions in the volatile cryptocurrency market.

Quickly understand the history and background of various well-known coins
Latest Articles
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.

Comments
No comments yet